Vaxxinity, Inc.
VAXX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | -100% | -88.2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $0 |
| Gross Profit | -$2 | -$2 | -$2 | $1 |
| % Margin | – | – | -2,834.8% | 90.7% |
| R&D Expenses | $34 | $48 | $71 | $21 |
| G&A Expenses | $22 | $28 | $52 | $12 |
| SG&A Expenses | $22 | $28 | $52 | $12 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2 | $0 | $0 |
| Operating Expenses | $56 | $74 | $123 | $33 |
| Operating Income | -$58 | -$76 | -$125 | -$32 |
| % Margin | – | – | -189,507.6% | -5,795.7% |
| Other Income/Exp. Net | $1 | $1 | -$12 | -$8 |
| Pre-Tax Income | -$0 | -$75 | -$137 | -$40 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$0 | -$75 | -$137 | -$40 |
| % Margin | – | – | -207,840.9% | -7,173.6% |
| EPS | -0.001 | -0.6 | -1.09 | -0.32 |
| % Growth | 99.9% | 45% | -240.6% | – |
| EPS Diluted | -0.001 | -0.6 | -1.09 | -0.32 |
| Weighted Avg Shares Out | 127 | 126 | 125 | 125 |
| Weighted Avg Shares Out Dil | 127 | 126 | 125 | 125 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $1 | $1 |
| EBITDA | -$54 | -$73 | -$135 | -$38 |
| % Margin | – | – | -204,898.5% | -6,832.7% |